Swiss National Bank Lowers Stake in Cabot Corporation $CBT

Swiss National Bank lessened its holdings in Cabot Corporation (NYSE:CBT) by 1.7% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 103,600 shares of the specialty chemicals company’s stock after selling 1,800 shares during the quarter. Swiss National Bank owned about 0.19% of Cabot worth $7,770,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in CBT. LSV Asset Management grew its stake in shares of Cabot by 318.0% in the 1st quarter. LSV Asset Management now owns 571,034 shares of the specialty chemicals company’s stock worth $47,476,000 after buying an additional 434,434 shares during the last quarter. American Century Companies Inc. boosted its holdings in Cabot by 13.2% in the first quarter. American Century Companies Inc. now owns 1,498,268 shares of the specialty chemicals company’s stock worth $124,566,000 after acquiring an additional 174,921 shares in the last quarter. AQR Capital Management LLC grew its stake in shares of Cabot by 79.5% in the first quarter. AQR Capital Management LLC now owns 389,244 shares of the specialty chemicals company’s stock worth $31,626,000 after acquiring an additional 172,410 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Cabot in the first quarter worth $12,365,000. Finally, Caisse DE Depot ET Placement DU Quebec increased its holdings in shares of Cabot by 279.2% during the first quarter. Caisse DE Depot ET Placement DU Quebec now owns 160,628 shares of the specialty chemicals company’s stock valued at $13,355,000 after acquiring an additional 118,266 shares in the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Trading Down 1.7%

Shares of CBT stock opened at $62.69 on Friday. The company has a current ratio of 2.13, a quick ratio of 1.41 and a debt-to-equity ratio of 0.66. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $115.16. The stock has a market capitalization of $3.32 billion, a P/E ratio of 8.19 and a beta of 0.90. The firm’s 50 day moving average is $68.02 and its 200 day moving average is $73.93.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). The firm had revenue of $899.00 million for the quarter, compared to analysts’ expectations of $967.02 million. Cabot had a net margin of 11.14% and a return on equity of 25.68%. The firm’s revenue was down 10.2% compared to the same quarter last year. During the same quarter last year, the company posted $1.80 EPS. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Research analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 12th. Stockholders of record on Friday, November 28th will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, November 28th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.9%. Cabot’s payout ratio is presently 29.95%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Wednesday, October 8th. Zacks Research cut shares of Cabot from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. UBS Group cut their price target on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Mizuho decreased their price objective on shares of Cabot from $78.00 to $72.00 and set an “outperform” rating for the company in a report on Monday, November 17th. Finally, JPMorgan Chase & Co. lowered their price objective on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research report on Friday. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus target price of $63.67.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.